Introduction: The reasons for wide variability in the incidence of decompression sickness (DCS) are not well known, but diet may play a role. The hypothesis of the present study was that raising plasma triglycerides via a high-fat meal would increase the rate of nitrogen washout and, therefore, might be a useful adjunct when denitrogenation is used to reduce the likelihood of DCS in diving and exposure to altitude.

Methods: Nitrogen elimination was measured for 125 min in 10 subjects by gas chromatography while they breathed a normoxic argon-oxygen mixture at sea level. Measurements were performed on separate days after high-fat and control, low-fat meals.

Results: The high-fat meal increased blood triglycerides by 236 +/- 86% while there was no significant change after the control meal. Despite causing a significant increase in cardiac output (21.6 +/- 13.8%), there was no difference in nitrogen elimination after high-fat (817.4 +/- 233.1 ml) vs. control (828.3 +/- 180.5 ml).

Discussion: These data suggest that raising blood triglycerides via a high-fat meal does not affect the rate of whole-body nitrogen elimination. The lack of effect of the increase in cardiac output may be due to an increased blood flow to the gastrointestinal tract being negated by decreased blood flow in other vascular beds.

Download full-text PDF

Source
http://dx.doi.org/10.3357/asem.2418.2011DOI Listing

Publication Analysis

Top Keywords

high-fat meal
12
nitrogen elimination
12
nitrogen washout
8
sea level
8
triglycerides high-fat
8
increased blood
8
blood triglycerides
8
increase cardiac
8
cardiac output
8
blood flow
8

Similar Publications

Lenacapavir is a potent, long-acting HIV-1 capsid inhibitor used in combination with other antiretrovirals to treat HIV-1 infection. The pharmacokinetics of orally administered drugs may be affected by food intake or coadministration of acid-reducing agents (ARA). Two Phase 1 studies were conducted on healthy participants to evaluate the effect of food and the impact of the histamine H-receptor antagonist famotidine in parallel cohorts.

View Article and Find Full Text PDF

Reduced food cravings correlated with a 24-month period of weight loss and weight maintenance.

Physiol Behav

January 2025

Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL, USA; Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, USA. Electronic address:

Food cravings increase calorie-dense food intake, contributing to weight gain. Although reductions in food cravings are frequently reported during weight loss, it remains unclear whether these changes are sustained during weight maintenance. The study objective was to investigate associations between food cravings and weight changes in a 12-month weight loss trial followed by 12 months of maintenance.

View Article and Find Full Text PDF

Sepiapterin is an exogenously synthesized new chemical entity that is structurally equivalent to endogenous sepiapterin, a biological precursor of tetrahydrobiopterin (BH), which is a cofactor for phenylalanine hydroxylase. Sepiapterin is being developed for the treatment of hyperphenylalaninemia in pediatric and adult patients with phenylketonuria (PKU). This study employed concentration-QT interval analysis to assess QT prolongation risk following sepiapterin treatment.

View Article and Find Full Text PDF

The simulation of antral conditions for estimating drug apparent equilibrium solubility after a high-calorie, high-fat meal is challenging. In this study, (1) we measured the apparent equilibrium solubility of two model lipophilic drugs, ketoconazole and danazol, in antral aspirates collected at various time points after a minced high-calorie, high-fat meal and a glass of water 30 min after initiation of meal administration, and we designated one point estimate for ketoconazole and one point estimate for danazol; (2) we evaluated the usefulness of FeSSGF-V2 and FEDGAS pH = 3 in reproducing the two point estimates; (3) we evaluated potential compositions of FeSSGF-V3 that simulate the pH, the buffer capacity toward both less acidic and more acidic values, and the antral lipid and protein contents with easily accessible, commercially available products, and (4) we identified the most useful composition of FeSSGF-V3 for reproducing the two point estimates. For both model drugs, apparent solubility in FeSSGF-V2 and in FEDGAS pH 3 deviated substantially from the corresponding point estimate.

View Article and Find Full Text PDF

Sotorasib is a novel KRAS inhibitor that has shown robust efficacy, safety, and tolerability in patients with KRAS mutation. The objectives of the population pharmacokinetic (PK) analysis were to characterize sotorasib population PK in healthy subjects and patients with advanced solid tumors with KRAS mutation from 6 clinical studies, evaluate the effects of intrinsic and extrinsic factors on PK parameters, and perform simulations to further assess the impact of identified covariates on sotorasib exposures. A two-compartment disposition model with three transit compartments for absorption and time-dependent clearance and bioavailability well described sotorasib PK.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!